George Vlachogiannis: A 10-year retrospective study of survival outcomes of patients with CRC liver oligometastases
George Vlachogiannis, Executive Editor of Cancer Control at Sage Publishing, shared an article by Xiao-Guang Qi, et al. on LinkedIn:
“A 10-year retrospective study of survival outcomes of patients with colorectal cancer (CRC) liver oligometastases (CLOM) based on right- vs left-sided primary CRC location reveals that right-sided primary tumors have worse survival outcomes post-ablation than left-sided ones.
The study reports a newly developed prognostic scoring model termed MRSL (Multiple liver metastases, Right-sided colon cancer, tumor Size ≥2 cm, Lymph node metastasis) which can help identify high-risk CRC patients with CLOM who may not benefit from ablation alone, emphasizing the need for incorporating additional therapeutic approaches in the management of these high-risk patients.”
Decision-Making for Ablation of Colorectal Liver Oligometastases Patients: A 10-Year Retrospective Study of Survival Outcomes Based on Right-Versus Left-Sided Primary Tumor Location.
Authors: Xiao-Guang Qi, et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023